Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway (Q36771955)
Jump to navigation
Jump to search
scientific article published on 4 December 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway |
scientific article published on 4 December 2015 |
Statements
Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway (English)
Deepak Kumar
Harrison Jones
Carlos I Amaya-Chanaga
Michael Y Choi
Amine Ale-Ali
Michelle R Kuhne
Peter Sabbatini
Lewis J Cohen
Suresh G Shelat
Laura Z Rassenti
Thomas J Kipps
Pina M Cardarelli
Januario E Castro
1 reference
1 reference